ATAI Life Sciences N.V.
NASDAQ: ATAI
$2.47
Closing price April 11, 2024
Here is a look of a few of the biggest clinical trial and FDA updates in regards to psychedelics to watch for in 2022.
Published:
Here's a quick look at six publicly traded companies developing ways to use psychedelics to treat mental health issues.
Published: